Clinical Trial Update: A Phase 2 Trial of JKN24011 in COPD [Phase 2]

View source ↗

Summary

This document provides a Phase 2 trial update for JKN24011 in chronic obstructive pulmonary disease, with the study currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• JKN24011

Snippet

Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd | Conditions: COPD (Chronic Obstructive Pulmonary Disease) | Phase 2 | Status: ACTIVE_NOT_RECRUITING